Alm. Brand A/S
Alm. Brand A/S – Weekly report on share buybacks
Alm. Brand A/S – Weekly report on share buybacks
Alm. Brand A/S share buy-back program
Transactions during 12 May 2025 – 16 May 2025
On 5 March 2025, Alm. Brand A/S announced a share buy-back program of up to DKK 835.2 million, as described in company announcement no. 21/2025.
The program is carried out in accordance with the Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.
The following transactions were made under the share buy-back program during week number 20:
Number of shares bought | Average purchase price | Amount (DKK) | |
Accumulated, last announcement | 11,460,000 | 15.74 | 178,619,900 |
12 May 2025 | 260,000 | 15.64 | 4,066,400 |
13 May 2025 | 260,000 | 15.70 | 4,082,000 |
14 May 2025 | 250,000 | 15.74 | 3,935,000 |
15 May 2025 | 200,000 | 15.93 | 3,186,000 |
16 May 2025 | 200,000 | 16.14 | 3,228,000 |
Total, week number 20 | 1,170,000 | 15.81 | 18,497,400 |
Accumulated under the program | 12,630,000 | 15.75 | 197,117,300 |
With the transactions stated above Alm. Brand A/S holds a total of 106,049,230 own shares corresponding to 6.88 % of the total number of outstanding shares.
Contact
Please direct any questions regarding this announcement to:
Investors and equity analysts:
Head of Investor Relations & ESG
Mads Thinggaard
Mobile no. +45 2025 5469
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Royal UNIBREW A/S19.5.2025 14:15:44 CEST | Press release
Share buy-back program
Duck Creek Technologies19.5.2025 14:10:00 CEST | Press release
Duck Creek Technologies Announces Tyler Jones as Chief Marketing Officer
Novonesis (Novozymes A/S)19.5.2025 14:00:00 CEST | Press release
Combining EVP roles of Human Health Biosolutions and Strategy & Integration
Biognosys AG19.5.2025 14:00:00 CEST | Press release
SISCAPA and Biognosys Announce Strategic Collaboration to Deliver End-to-End High-Sensitivity Targeted Protein Quantification Solutions
Novonesis (Novozymes A/S)19.5.2025 13:50:52 CEST | Press release
Transactions under Novonesis’ share buyback program
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom